What is the 13F Pro Quality Score for ALGN?

13F Pro ranks ALIGN TECHNOLOGY INC (ALGN) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ALGN's current score at https://13fpro.ai/company/ALGN (free sign-up required for the full ranking).

Which hedge funds own the most ALGN stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of ALGN include BlackRock,, VANGUARD CAPITAL MANAGEMENT, FMR. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/ALGN as soon as new 13F filings post.

Where does 13F Pro source ALGN data?

All ALIGN TECHNOLOGY INC fundamentals and ownership data come directly from SEC EDGAR. ALIGN TECHNOLOGY INC files with the SEC under CIK 1097149. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ALGN in?

ALIGN TECHNOLOGY INC (ALGN) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ALGN research updated on 13F Pro?

ALGN's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

ALIGN TECHNOLOGY INC(ALGN)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqlarge

Institutional-grade research for retail investors

SEC EDGAR: CIK 1097149 ALGN stock profile & AI dashboard →

13F Pro Quality Score

58.9/100

Rank #965 of 2,961 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

30.6/100

Profitability

60.1/100

Balance Sheet

75.6/100

Earnings Quality

81.1/100

Free Cash Flow

65.7/100

Institutional Flow

77.5/100

Revenue Scale

75.4/100

Dilution Risk

26.0/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why ALGN Scores 59/100

exact factor attribution · 2026-09-11

ALGN's composite is driven by scale and earnings quality, held back by revenue growth and shareholder dilution. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Scale

+3.8 pts

75th pct

Earnings quality

+3.1 pts

81th pct

Capital efficiency

+2.6 pts

76th pct

Free cash flow

+2.4 pts

66th pct

Profitability

+1.5 pts

60th pct

Institutional flow

+1.4 pts

78th pct

Earnings growth

-0.8 pts

35th pct

Shareholder dilution

-1.2 pts

26th pct

Revenue growth

-3.9 pts

31th pct

Latest change (2026-08-06): 58 → 60 · ↑ Free cash flow 65→74

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

ALGN Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for ALIGN TECHNOLOGY INC (ALGN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ALGN at 58.9/100 on a 32-signal composite quality model, placing it at rank #965 of 2,961 stocks — the top half of the AI-ranked universe. ALGN scores in the top quartile across earnings quality (81.1), institutional flow (77.5), balance sheet strength (75.6). Areas of concern include revenue growth (30.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 26.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ALIGN TECHNOLOGY INC reports quarterly revenue of $1.1B, net income of $108.3M, an operating margin of 14.6%. Top institutional holders of ALGN by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, FMR, based on the most recent SEC filings. ALGN trades on the Nasdaq exchange and files with the SEC under CIK 1097149. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALGN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ALIGN TECHNOLOGY INC directly from SEC EDGAR. ALIGN TECHNOLOGY INC's 13F Pro composite quality score has ranged between 54 and 81 since 2021, currently 58.9 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.

✦

Fun facts about ALIGN TECHNOLOGY INC

Quirks, history, and lore behind ALGN — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. medical device company · mid-to-large cap · listed on Nasdaq · headquartered in Arizona.
2
The Numbers
Annual revenue roughly $4 billion, with customers in over 100 countries — proving that vanity is a global market.
3
The History
Founded in the late 1990s by two Stanford MBA students who reportedly hated their own metal braces and decided to disrupt a centuries-old profession.
4
The Secret
It doesn't just sell a product — it sells a doctor-exclusive ecosystem, locking orthodontists and dentists into its proprietary digital treatment platform.
5
The Lore
It pioneered the use of 3D printing and computer modeling in orthodontics and has manufactured well over 10 million patient treatments since launch.
6
The Giveaway
No metal. No wires. Just a series of clear removable plastic aligners that straighten teeth — and the company that invented the whole Invisalign category.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$1.1B

Net Income

Q2 2026

$108.3M

Free Cash Flow

Q2 2026

$157.1M

Operating Margin

Q2 2026

14.6%

ROIC

Q2 2026

14.6%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+0.9% YoY

$4.03BFY 2025

FY22 $3.73BFY23 $3.86BFY24 $4.00BFY25 $4.03B

Net Income

-2.6% YoY

$410.4MFY 2025

FY22 $361.6MFY23 $445.1MFY24 $421.4MFY25 $410.4M

Operating Income

-10.2% YoY

$545.8MFY 2025

FY22 $642.6MFY23 $643.3MFY24 $607.6MFY25 $545.8M

EPS (Diluted)

+0.5% YoY

$5.65FY 2025

FY22 $4.61FY23 $5.81FY24 $5.62FY25 $5.65

Total Assets

+0.3% YoY

$6.23BFY 2025

FY22 $5.95BFY23 $6.08BFY24 $6.21BFY25 $6.23B

Op. Cash Flow

-19.6% YoY

$593.2MFY 2025

FY22 $568.7MFY23 $785.8MFY24 $738.2MFY25 $593.2M

Free Cash Flow

-21.2% YoY

$490.8MFY 2025

FY22 $276.8MFY23 $608.1MFY24 $622.7MFY25 $490.8M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$4.03B +0.9%	$4.00B +3.5%	$3.86B +3.4%	$3.73B -5.5%	$3.95B +59.9%	$2.47B
Net Income	$410.4M -2.6%	$421.4M -5.3%	$445.1M +23.1%	$361.6M -53.2%	$772.0M -56.5%	$1.78B
Operating Income	$545.8M -10.2%	$607.6M -5.6%	$643.3M +0.1%	$642.6M -34.2%	$976.4M +152.2%	$387.2M
EPS (Diluted)	$5.65 +0.5%	$5.62 -3.3%	$5.81 +26.0%	$4.61 -52.4%	$9.69 -56.8%	$22.41
Total Assets	$6.23B +0.3%	$6.21B +2.1%	$6.08B +2.3%	$5.95B +0.1%	$5.94B +23.0%	$4.83B
Operating Cash Flow	$593.2M -19.6%	$738.2M -6.1%	$785.8M +38.2%	$568.7M -51.5%	$1.17B +77.1%	$662.2M
Free Cash Flow	$490.8M -21.2%	$622.7M +2.4%	$608.1M +119.6%	$276.8M -64.1%	$771.4M +52.1%	$507.3M

Get alerted when ALGN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for ALIGN TECHNOLOGY INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ALGN

BlackRock, Inc.
$745.4M4,419,366 sh
VANGUARD CAPITAL MANAGEMENT LLC
$742.3M4,401,313 sh
FMR LLC
$684.8M4,060,032 sh
Capital International Investors
$682.3M4,045,561 sh
Capital World Investors
$577.2M3,422,385 sh
GOLDMAN SACHS GROUP INC
$568.8M3,372,760 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$528.2M3,131,764 sh
STATE STREET CORP
$431.5M2,558,512 sh
GEODE CAPITAL MANAGEMENT, LLC
$378.2M2,245,315 sh
Ninety One UK Ltd
$372.7M2,209,791 sh

Fund	Value	Shares
BlackRock, Inc.	$745.4M	4,419,366
VANGUARD CAPITAL MANAGEMENT LLC	$742.3M	4,401,313
FMR LLC	$684.8M	4,060,032
Capital International Investors	$682.3M	4,045,561
Capital World Investors	$577.2M	3,422,385
GOLDMAN SACHS GROUP INC	$568.8M	3,372,760
VANGUARD PORTFOLIO MANAGEMENT LLC	$528.2M	3,131,764
STATE STREET CORP	$431.5M	2,558,512
GEODE CAPITAL MANAGEMENT, LLC	$378.2M	2,245,315
Ninety One UK Ltd	$372.7M	2,209,791

Companies Similar to ALGN

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

BIIB

BIOGEN INC.

AI score

Very similar · 22 shared holders

LSV ASSET MANAGEMENT Swedbank AB CAISSE DE DEPOT ET PLACEMENT DU QUEBEC

IQV

IQVIA HOLDINGS INC.

AI score

Very similar · 14 shared holders

Capital World Investors Artisan Partners Limited Partnership COUNTRY TRUST BANK

REGN

REGENERON PHARMACEUTICALS, INC.

AI score

Very similar · 27 shared holders

Capital World Investors JACOBS LEVY EQUITY MANAGEMENT, INC Swedbank AB

ZBH

ZIMMER BIOMET HOLDINGS, INC.

AI score

Similar quality profile · 17 shared holders

Capital International Investors LSV ASSET MANAGEMENT Boston Partners

PODD

INSULET CORP

AI score

Similar quality profile · 25 shared holders

Capital World Investors Artisan Partners Limited Partnership CAISSE DE DEPOT ET PLACEMENT DU QUEBEC

COO

COOPER COMPANIES, INC.

AI score

Similar quality profile · 19 shared holders

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Capital World Investors Bellevue Group AG

WST

WEST PHARMACEUTICAL SERVICES INC

AI score

Similar quality profile · 22 shared holders

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC JACOBS LEVY EQUITY MANAGEMENT, INC Ninety One UK Ltd

ZTS

Zoetis Inc.

AI score

Similar quality profile · 15 shared holders

Ruane, Cunniff & Goldfarb L.P.Swedbank AB Carmignac Gestion

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ALGN on your watchlist

Track score changes the day ALIGN TECHNOLOGY INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ALGN a good stock to buy?

13F Pro's AI-powered analysis of ALIGN TECHNOLOGY INC (ALGN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ALGN are available on the ALGN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ALGN is classified as a large company.

Which hedge funds own ALGN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ALGN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ALIGN TECHNOLOGY INC's investment landscape.